Extract

A news story in the Aug. 16, 2006, issue (“Two Targets, One Drug for New EGFR Inhibitors,” Vol. 98, No. 16, 1102–1103 ) incorrectly stated the targets of the drug ZD6474. The drug is targeted at EGFR, VEGFR, and the RET kinase.

You do not currently have access to this article.